HomeOwner SearchCategory Search
Visit USCOCardiovascular Drugs and Therapy [Published: 2016-11-01. Issue: vol. 30, no. 5, 2016]
Serial Registration
Copyright Title
Cardiovascular Drugs and Therapy [Published: 2016-11-01. Issue: vol. 30, no. 5, 2016]
Status
Published
on 10 Feb 2017
Year of Creation
2016
Copyright Claimant
Springer Science+Business Media LLC
Registration Number
TX0008354432
on 10 Feb 2017Copyright Summary
The U.S. Copyright record (Registration Number: TX0008354432) dated 10 Feb 2017, pertains to an electronic file (eService) titled "Cardiovascular Drugs and Therapy [Published: 2016-11-01. Issue: vol. 30, no. 5, 2016]" created in 2016. The copyright holder is Springer Science+Business Media LLC, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Springer Science+Business Media LLC.
Application Details
Registration Number
TX0008354432
Registration Date
2/10/2017
Year of Creation
2016
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Springer Science+Business Media LLC
First Publication Nation
United States
ISSN
0920-3206
Preexisting Material
artwork, photograph(s), text, previously published online
Notes
Copyright Local Holdings: vol. 30, no. 5, 2016 Created 2016 Pub. 2016-11-01 Reg. 2017-02-15 TX0008354432 JMOO
Material Matter Claimed Note: compilation
Statements
Application Title Statement: Cardiovascular Drugs and Therapy
Author Statement: Springer Science+Business Media LLC employer for hire Domicile: United States Citizenship: United States Authorship: compilation
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.